{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,4]],"date-time":"2026-03-04T08:31:49Z","timestamp":1772613109983,"version":"3.50.1"},"reference-count":56,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2022,3,30]],"date-time":"2022-03-30T00:00:00Z","timestamp":1648598400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,3,30]],"date-time":"2022-03-30T00:00:00Z","timestamp":1648598400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100001501","name":"university grants commission","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001501","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001409","name":"department of science and technology, ministry of science and technology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001409","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Biometals"],"published-print":{"date-parts":[[2022,6]]},"DOI":"10.1007\/s10534-022-00384-7","type":"journal-article","created":{"date-parts":[[2022,3,30]],"date-time":"2022-03-30T20:03:01Z","timestamp":1648670581000},"page":"499-517","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["A family of amphiphilic dioxidovanadium(V) hydrazone complexes as potent carbonic anhydrase inhibitors along with anti-diabetic and cytotoxic activities"],"prefix":"10.1007","volume":"35","author":[{"given":"Chiranjit","family":"Ghosh","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Debashis","family":"Patra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Niranjan","family":"Bala","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Indira","family":"Majumder","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nayim","family":"Sepay","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Prabuddha","family":"Mukhopadhyay","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sukhen","family":"Das","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rita","family":"Kundu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael G. B.","family":"Drew","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Armando Rafael","family":"Le\u00f3n","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tapas","family":"Ghosh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manik","family":"Pradhan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,3,30]]},"reference":[{"key":"384_CR1","unstructured":"ABSPACK S. (2005) An Oxford Diffraction Program. Diffraction, Ltd, UK"},{"key":"384_CR2","doi-asserted-by":"publisher","first-page":"5137","DOI":"10.1016\/S0021-9258(18)99681-X","volume":"241","author":"JM Armstrong","year":"1966","unstructured":"Armstrong JM, Myers DV, Verpoorte JA, Edsall JT (1966) Purification and properties of human erythrocyte carbonic anhydrases. J Biol Chem 241:5137\u20135149","journal-title":"J Biol Chem"},{"key":"384_CR3","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1002\/cbic.201600513","volume":"18","author":"A Bhatt","year":"2017","unstructured":"Bhatt A, Mahon BP, Cruzeiro VWD et al (2017) Structure-activity relationships of benzenesulfonamide-based inhibitors towards carbonic anhydrase isoform specificity. ChemBioChem 18:213\u2013222. https:\/\/doi.org\/10.1002\/cbic.201600513","journal-title":"ChemBioChem"},{"key":"384_CR4","doi-asserted-by":"publisher","first-page":"1153","DOI":"10.1039\/C7CC07549A","volume":"54","author":"A Bijelic","year":"2018","unstructured":"Bijelic A, Aureliano M, Rompel A (2018) The antibacterial activity of polyoxometalates: structures, antibiotic effects and future perspectives. Chem Commun 54:1153\u20131169. https:\/\/doi.org\/10.1039\/C7CC07549A","journal-title":"Chem Commun"},{"key":"384_CR5","doi-asserted-by":"publisher","first-page":"2980","DOI":"10.1002\/anie.201803868","volume":"58","author":"A Bijelic","year":"2019","unstructured":"Bijelic A, Aureliano M, Rompel A (2019) Polyoxometalates as potential next-generation metallodrugs in the combat against cancer. Angew Chemie Int Ed 58:2980\u20132999. https:\/\/doi.org\/10.1002\/anie.201803868","journal-title":"Angew Chemie Int Ed"},{"key":"384_CR6","doi-asserted-by":"publisher","first-page":"1293","DOI":"10.1038\/nature08933","volume":"464","author":"JA Bluestone","year":"2010","unstructured":"Bluestone JA, Herold K, Eisenbarth G (2010) Genetics, pathogenesis and clinical interventions in type 1 diabetes. Nature 464:1293\u20131300. https:\/\/doi.org\/10.1038\/nature08933","journal-title":"Nature"},{"key":"384_CR7","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1016\/j.ecl.2008.06.007","volume":"37","author":"G Boden","year":"2008","unstructured":"Boden G (2008) Obesity and free fatty acids. Endocrinol Metab Clin North Am 37:635\u2013646. https:\/\/doi.org\/10.1016\/j.ecl.2008.06.007","journal-title":"Endocrinol Metab Clin North Am"},{"key":"384_CR8","unstructured":"Botr\u00e8 F., Gros G. SBT (1991) Carbonic Anhydrase: From Biochemistry and Genetics to Physiology and Clinical Medicine: Proceedings of the International Workshop on Carbonic Anhydrase, Held in Spoleto, Italy in March 1990. VCH Verlagsgesellschaft 352\u2013374"},{"key":"384_CR9","doi-asserted-by":"publisher","first-page":"394","DOI":"10.3322\/caac.21492","volume":"68","author":"F Bray","year":"2018","unstructured":"Bray F, Ferlay J, Soerjomataram I et al (2018) Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 68:394\u2013424. https:\/\/doi.org\/10.3322\/caac.21492","journal-title":"CA Cancer J Clin"},{"key":"384_CR10","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1039\/C9CC07683B","volume":"56","author":"Z Chen","year":"2020","unstructured":"Chen Z, Lai H, Hou L, Chen T (2020) Rational design and action mechanisms of chemically innovative organoselenium in cancer therapy. Chem Commun 56:179\u2013196. https:\/\/doi.org\/10.1039\/C9CC07683B","journal-title":"Chem Commun"},{"key":"384_CR11","doi-asserted-by":"publisher","first-page":"1305","DOI":"10.1021\/ja00083a016","volume":"116","author":"DC Crans","year":"1994","unstructured":"Crans DC, Shin PK (1994) Characterization of Vanadium(V) complexes in aqueous solutions: ethanolamine- and glycine-derived complexes. J Am Chem Soc 116:1305\u20131315. https:\/\/doi.org\/10.1021\/ja00083a016","journal-title":"J Am Chem Soc"},{"key":"384_CR12","doi-asserted-by":"publisher","first-page":"5447","DOI":"10.1021\/ja9701671","volume":"119","author":"DC Crans","year":"1997","unstructured":"Crans DC, Keramidas AD, Hoover-Litty H et al (1997) Synthesis, structure, and biological activity of a new insulinomimetic peroxovanadium compound: bisperoxovanadium imidazole monoanion. J Am Chem Soc 119:5447\u20135448. https:\/\/doi.org\/10.1021\/ja9701671","journal-title":"J Am Chem Soc"},{"key":"384_CR13","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1021\/cr020607t","volume":"104","author":"DC Crans","year":"2004","unstructured":"Crans DC, Smee JJ, Gaidamauskas E, Yang L (2004) The chemistry and biochemistry of vanadium and the biological activities exerted by vanadium compounds. Chem Rev 104:849\u2013902. https:\/\/doi.org\/10.1021\/cr020607t","journal-title":"Chem Rev"},{"key":"384_CR14","doi-asserted-by":"publisher","first-page":"4245","DOI":"10.1021\/ic100080k","volume":"49","author":"DC Crans","year":"2010","unstructured":"Crans DC, Zhang B, Gaidamauskas E et al (2010) Is vanadate reduced by thiols under biological conditions? changing the redox potential of V(V)\/V(IV) by complexation in aqueous solution. Inorg Chem 49:4245\u20134256. https:\/\/doi.org\/10.1021\/ic100080k","journal-title":"Inorg Chem"},{"key":"384_CR15","doi-asserted-by":"publisher","first-page":"2178","DOI":"10.1016\/j.ccr.2011.01.032","volume":"255","author":"DC Crans","year":"2011","unstructured":"Crans DC, Trujillo AM, Pharazyn PS, Cohen MD (2011) How environment affects drug activity: Localization, compartmentalization and reactions of a vanadium insulin-enhancing compound, dipicolinatooxovanadium(V). Coord Chem Rev 255:2178\u20132192. https:\/\/doi.org\/10.1016\/j.ccr.2011.01.032","journal-title":"Coord Chem Rev"},{"key":"384_CR16","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1023\/a:1007067011338","volume":"203","author":"JL Domingo","year":"2000","unstructured":"Domingo JL (2000) Vanadium and diabetes. What about vanadium toxicity? Mol Cell Biochem 203:185\u2013187. https:\/\/doi.org\/10.1023\/a:1007067011338","journal-title":"Mol Cell Biochem"},{"key":"384_CR17","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1111\/j.1600-0773.1991.tb01233.x","volume":"68","author":"JL Domingo","year":"1991","unstructured":"Domingo JL, G\u00f3mez M, Llobet JM et al (1991) Improvement of glucose homeostasis by oral vanadyl or vanadate treatment in diabetic rats is accompanied by negative side effects. Pharmacol Toxicol 68:249\u2013253. https:\/\/doi.org\/10.1111\/j.1600-0773.1991.tb01233.x","journal-title":"Pharmacol Toxicol"},{"key":"384_CR18","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1016\/S1040-8428(01)00221-9","volume":"42","author":"AM Evangelou","year":"2002","unstructured":"Evangelou AM (2002) Vanadium in cancer treatment. Crit Rev Oncol Hematol 42:249\u2013265. https:\/\/doi.org\/10.1016\/S1040-8428(01)00221-9","journal-title":"Crit Rev Oncol Hematol"},{"key":"384_CR19","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1002\/jat.2550110307","volume":"11","author":"M G\u00f3mez","year":"1991","unstructured":"G\u00f3mez M, Domingo JL, Llobet JM, Corbella J (1991) Effectiveness of some chelating agents on distribution and excretion of vanadium in rats after prolonged oral administration. J Appl Toxicol 11:195\u2013198. https:\/\/doi.org\/10.1002\/jat.2550110307","journal-title":"J Appl Toxicol"},{"key":"384_CR20","doi-asserted-by":"publisher","first-page":"1196","DOI":"10.1002\/chem.201903232","volume":"26","author":"OO Grygorenko","year":"2020","unstructured":"Grygorenko OO, Volochnyuk DM, Ryabukhin SV, Judd DB (2020) The symbiotic relationship between drug discovery and organic chemistry. Chem Eur J 26:1196\u20131237. https:\/\/doi.org\/10.1002\/chem.201903232","journal-title":"Chem Eur J"},{"key":"384_CR21","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1063\/1.448975","volume":"82","author":"PJ Hay","year":"1985","unstructured":"Hay PJ, Wadt WR (1985) Ab initio effective core potentials for molecular calculations. Potentials for K to Au including the outermost core orbitals. J Chem Phys 82:299\u2013310. https:\/\/doi.org\/10.1063\/1.448975","journal-title":"J Chem Phys"},{"key":"384_CR22","doi-asserted-by":"publisher","first-page":"8383","DOI":"10.1039\/C5TB01501D","volume":"3","author":"L He","year":"2015","unstructured":"He L, Ji S, Lai H, Chen T (2015) Selenadiazole derivatives as theranostic agents for simultaneous cancer chemo-\/radiotherapy by targeting thioredoxin reductase. J Mater Chem B 3:8383\u20138393. https:\/\/doi.org\/10.1039\/C5TB01501D","journal-title":"J Mater Chem B"},{"key":"384_CR23","doi-asserted-by":"publisher","first-page":"5104","DOI":"10.1021\/ja043944n","volume":"127","author":"BD Liboiron","year":"2005","unstructured":"Liboiron BD, Thompson KH, Hanson GR et al (2005) New insights into the interactions of serum proteins with Bis(maltolato)oxovanadium(IV): transport and biotransformation of insulin-enhancing vanadium pharmaceuticals. J Am Chem Soc 127:5104\u20135115. https:\/\/doi.org\/10.1021\/ja043944n","journal-title":"J Am Chem Soc"},{"key":"384_CR24","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1080\/14756360410001689595","volume":"19","author":"CZH Mahmood-Ul-Hassan","year":"2004","unstructured":"Mahmood-Ul-Hassan CZH, Scozzafava A, Supuran CT (2004) Carbonic anhydrase inhibitors: Schiff\u2019s bases of aromatic and heterocyclic sulfonamides and their metal complexes. J Enzyme Inhib Med Chem 19:263\u2013267. https:\/\/doi.org\/10.1080\/14756360410001689595","journal-title":"J Enzyme Inhib Med Chem"},{"key":"384_CR25","doi-asserted-by":"publisher","first-page":"798","DOI":"10.1021\/jm701146c","volume":"51","author":"C Marzano","year":"2008","unstructured":"Marzano C, Gandin V, Pellei M et al (2008) In vitro antitumor activity of the water soluble copper(I) complexes bearing the Tris(hydroxymethyl)phosphine ligand. J Med Chem 51:798\u2013808. https:\/\/doi.org\/10.1021\/jm701146c","journal-title":"J Med Chem"},{"key":"384_CR26","doi-asserted-by":"publisher","first-page":"2288","DOI":"10.1021\/ic981231y","volume":"38","author":"M Melchior","year":"1999","unstructured":"Melchior M, Thompson KH, Jong JM et al (1999) Vanadium complexes as insulin mimetic agents: coordination chemistry and in vivo studies of oxovanadium(IV) and dioxovanadate(V) complexes formed from naturally occurring chelating oxazolinate, thiazolinate, or picolinate units. Inorg Chem 38:2288\u20132293. https:\/\/doi.org\/10.1021\/ic981231y","journal-title":"Inorg Chem"},{"key":"384_CR27","doi-asserted-by":"publisher","first-page":"4540","DOI":"10.1021\/cr400460s","volume":"114","author":"KD Mjos","year":"2014","unstructured":"Mjos KD, Orvig C (2014) Metallodrugs in medicinal inorganic chemistry. Chem Rev 114:4540\u20134563. https:\/\/doi.org\/10.1021\/cr400460s","journal-title":"Chem Rev"},{"key":"384_CR28","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0169809","volume":"12","author":"S Mukherjee","year":"2017","unstructured":"Mukherjee S, Chattopadhyay M, Bhattacharya S et al (2017) A small insulinomimetic molecule also improves insulin sensitivity in diabetic mice. PLoS ONE 12:e0169809. https:\/\/doi.org\/10.1371\/journal.pone.0169809","journal-title":"PLoS ONE"},{"key":"384_CR29","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1002\/ejic.200300421","volume":"2004","author":"P Nobl\u00eda","year":"2004","unstructured":"Nobl\u00eda P, Baran EJ, Otero L et al (2004) New vanadium( <scp>V<\/scp> ) complexes with salicylaldehyde semicarbazone derivatives: synthesis, characterization, and in vitro insulin-mimetic activity \u2212 crystal structure of [V v O 2 (salicylaldehyde semicarbazone)]. Eur J Inorg Chem 2004:322\u2013328. https:\/\/doi.org\/10.1002\/ejic.200300421","journal-title":"Eur J Inorg Chem"},{"key":"384_CR30","doi-asserted-by":"publisher","first-page":"17603","DOI":"10.1039\/C9NJ01638D","volume":"43","author":"JE Parente","year":"2019","unstructured":"Parente JE, Naso LG, Jori K et al (2019) In vitro experiments and infrared spectroscopy analysis of acid and alkaline phosphatase inhibition by vanadium complexes. New J Chem 43:17603\u201317619. https:\/\/doi.org\/10.1039\/C9NJ01638D","journal-title":"New J Chem"},{"key":"384_CR31","first-page":"779","volume":"23","author":"R Parui","year":"1991","unstructured":"Parui R, Gambhir KK, Mehrotra PP (1991) Changes in carbonic anhydrase may be the initial step of altered metabolism in hypertension. Biochem Int 23:779\u2013789","journal-title":"Biochem Int"},{"key":"384_CR32","doi-asserted-by":"publisher","first-page":"92456","DOI":"10.1039\/C5RA17844D","volume":"5","author":"D Patra","year":"2015","unstructured":"Patra D, Biswas N, Kumari B et al (2015) A family of mixed-ligand oxidovanadium( <scp>v<\/scp> ) complexes with aroylhydrazone ligands: a combined experimental and computational study on the electronic effects of para substituents of hydrazone ligands on the electronic properties, DNA binding and. RSC Adv 5:92456\u201392472. https:\/\/doi.org\/10.1039\/C5RA17844D","journal-title":"RSC Adv"},{"key":"384_CR350","doi-asserted-by":"publisher","unstructured":"Patra D, Paul S, Majumder I et al (2017) Exploring the effect of substituent in the hydrazone ligand of a family of \u03bc-oxidodivanadium (v) hydrazone complexes on structure, DNA binding and anticancer activity. Dalton Trans 46:16276\u201316293. https:\/\/doi.org\/10.1039\/C7DT03585C","DOI":"10.1039\/C7DT03585C"},{"key":"384_CR33","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1016\/j.diabet.2017.06.003","volume":"43","author":"G Reach","year":"2017","unstructured":"Reach G, Pechtner V, Gentilella R et al (2017) Clinical inertia and its impact on treatment intensification in people with type 2 diabetes mellitus. Diabetes Metab 43:501\u2013511. https:\/\/doi.org\/10.1016\/j.diabet.2017.06.003","journal-title":"Diabetes Metab"},{"key":"384_CR34","first-page":"81","volume":"3","author":"A Sachin","year":"2009","unstructured":"Sachin A, Shreesh KO, Divya V (2009) Characterization of streptozotocin induced diabetes mellitus in swiss albino mice. Glob J Pharmacol 3:81\u201384","journal-title":"Glob J Pharmacol"},{"key":"384_CR35","doi-asserted-by":"publisher","first-page":"107843","DOI":"10.1016\/j.diabres.2019.107843","volume":"157","author":"P Saeedi","year":"2019","unstructured":"Saeedi P, Petersohn I, Salpea P et al (2019) Global and regional diabetes prevalence estimates for 2019 and projections for 2030 and 2045: Results from the International Diabetes Federation Diabetes Atlas, 9th edition. Diabetes Res Clin Pract 157:107843. https:\/\/doi.org\/10.1016\/j.diabres.2019.107843","journal-title":"Diabetes Res Clin Pract"},{"key":"384_CR36","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1016\/0006-291X(80)91213-9","volume":"96","author":"H Sakurai","year":"1980","unstructured":"Sakurai H, Shimomura S, Fukuzawa K, Ishizu K (1980) Detection of oxovanadium(IV) and characterization of its ligand environment in subcellular fractions of the liver of rats treated with pentavalent vanadium(V). Biochem Biophys Res Commun 96:293\u2013298. https:\/\/doi.org\/10.1016\/0006-291X(80)91213-9","journal-title":"Biochem Biophys Res Commun"},{"key":"384_CR37","doi-asserted-by":"publisher","first-page":"193","DOI":"10.3164\/jcbn.8.193","volume":"8","author":"H Sakurai","year":"1990","unstructured":"Sakurai H, Tsuchiya K, Nukatsuka M et al (1990) Insulin-mimetic action of vanadyl complexes. J Clin Biochem Nutr 8:193\u2013200. https:\/\/doi.org\/10.3164\/jcbn.8.193","journal-title":"J Clin Biochem Nutr"},{"key":"384_CR38","doi-asserted-by":"publisher","DOI":"10.3389\/fchem.2018.00402","author":"E S\u00e1nchez-Lara","year":"2018","unstructured":"S\u00e1nchez-Lara E, Trevi\u00f1o S, S\u00e1nchez-Gayt\u00e1n BL et al (2018) Decavanadate salts of cytosine and metformin: a combined experimental-theoretical study of potential metallodrugs against diabetes and cancer. Front Chem. https:\/\/doi.org\/10.3389\/fchem.2018.00402","journal-title":"Front Chem"},{"key":"384_CR39","doi-asserted-by":"publisher","first-page":"96016","DOI":"10.1039\/C6RA13584F","volume":"6","author":"N Sepay","year":"2016","unstructured":"Sepay N, Mallik S, Guha C, Mallik AK (2016) An efficient synthesis of 1,3-dimethyl-5-(2-phenyl-4H-chromen-4-ylidene) pyrimidine-2,4,6(1H,3H,5H)-triones and investigation of their interactions with \u03b2-lactoglobiulin. RSC Adv 6:96016\u201396024. https:\/\/doi.org\/10.1039\/C6RA13584F","journal-title":"RSC Adv"},{"key":"384_CR40","doi-asserted-by":"publisher","first-page":"1","DOI":"10.2337\/diacare.39.1.1","volume":"39","author":"Y Shechter","year":"1990","unstructured":"Shechter Y (1990) Insulin-mimetic effects of vanadate: possible implications for future treatment of diabetes. Diabetes 39:1\u20135. https:\/\/doi.org\/10.2337\/diacare.39.1.1","journal-title":"Diabetes"},{"key":"384_CR41","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1038\/284556a0","volume":"284","author":"Y Shechter","year":"1980","unstructured":"Shechter Y, Karlish SJD (1980) Insulin-like stimulation of glucose oxidation in rat adipocytes by vanadyl (IV) ions. Nature 284:556\u2013558. https:\/\/doi.org\/10.1038\/284556a0","journal-title":"Nature"},{"key":"384_CR42","doi-asserted-by":"publisher","first-page":"1357","DOI":"10.1021\/ic0111684","volume":"41","author":"B Song","year":"2002","unstructured":"Song B, Aebischer N, Orvig C (2002) Reduction of [VO 2 (ma) 2 ] - and [VO 2 (ema) 2 ] - by ascorbic acid and glutathione: kinetic studies of pro-drugs for the enhancement of insulin action. Inorg Chem 41:1357\u20131364. https:\/\/doi.org\/10.1021\/ic0111684","journal-title":"Inorg Chem"},{"key":"384_CR43","doi-asserted-by":"publisher","first-page":"15584","DOI":"10.3390\/molecules191015584","volume":"19","author":"S Spreckelmeyer","year":"2014","unstructured":"Spreckelmeyer S, Orvig C, Casini A (2014) Cellular transport mechanisms of cytotoxic metallodrugs: an overview beyond cisplatin. Molecules 19:15584\u201315610. https:\/\/doi.org\/10.3390\/molecules191015584","journal-title":"Molecules"},{"key":"384_CR44","doi-asserted-by":"publisher","first-page":"5528","DOI":"10.1021\/ja068359w","volume":"129","author":"DK Srivastava","year":"2007","unstructured":"Srivastava DK, Jude KM, Banerjee AL et al (2007) Structural analysis of charge discrimination in the binding of inhibitors to human carbonic anhydrases I and II. J Am Chem Soc 129:5528\u20135537. https:\/\/doi.org\/10.1021\/ja068359w","journal-title":"J Am Chem Soc"},{"key":"384_CR45","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1080\/17460441.2017.1253677","volume":"12","author":"CT Supuran","year":"2017","unstructured":"Supuran CT (2017) Advances in structure-based drug discovery of carbonic anhydrase inhibitors. Expert Opin Drug Discov 12:61\u201388. https:\/\/doi.org\/10.1080\/17460441.2017.1253677","journal-title":"Expert Opin Drug Discov"},{"key":"384_CR46","doi-asserted-by":"publisher","DOI":"10.1002\/9780470508169","volume-title":"Drug Design of Zinc-Enzyme Inhibitors","author":"CT Supuran","year":"2009","unstructured":"Supuran CT, Winum JY (2009) Drug Design of Zinc-Enzyme Inhibitors. John Wiley & Sons Inc, Hoboken, NJ, USA"},{"key":"384_CR47","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1002\/med.10025","volume":"23","author":"CT Supuran","year":"2003","unstructured":"Supuran CT, Scozzafava A, Casini A (2003) Carbonic anhydrase inhibitors. Med Res Rev 23:146\u2013189. https:\/\/doi.org\/10.1002\/med.10025","journal-title":"Med Res Rev"},{"key":"384_CR48","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1080\/13543776.2019.1679117","volume":"29","author":"CT Supuran","year":"2019","unstructured":"Supuran CT, Altamimi ASA, Carta F (2019) Carbonic anhydrase inhibition and the management of glaucoma: a literature and patent review 2013\u20132019. Expert Opin Ther Pat 29:781\u2013792. https:\/\/doi.org\/10.1080\/13543776.2019.1679117","journal-title":"Expert Opin Ther Pat"},{"key":"384_CR49","doi-asserted-by":"publisher","DOI":"10.1002\/jbt.21973","volume":"31","author":"P Taslimi","year":"2017","unstructured":"Taslimi P, Ak\u0131nc\u0131oglu H, G\u00fcl\u00e7in \u0130 (2017) Synephrine and phenylephrine act as \u03b1-amylase, \u03b1-glycosidase, acetylcholinesterase, butyrylcholinesterase, and carbonic anhydrase enzymes inhibitors. J Biochem Mol Toxicol 31:e21973. https:\/\/doi.org\/10.1002\/jbt.21973","journal-title":"J Biochem Mol Toxicol"},{"key":"384_CR50","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1039\/b416256k","volume":"35","author":"KH Thompson","year":"2006","unstructured":"Thompson KH, Barta CA, Orvig C (2006) Metal complexes of maltol and close analogues in medicinal inorganic chemistry. Chem Soc Rev 35:545. https:\/\/doi.org\/10.1039\/b416256k","journal-title":"Chem Soc Rev"},{"key":"384_CR51","doi-asserted-by":"crossref","unstructured":"Tracey AS, Willsky GR, Takeuchi ES (2007) Vanadium: Chemistry, Biochemistry, Pharmacology and Practical Applications","DOI":"10.1201\/9781420046144"},{"key":"384_CR52","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1016\/j.bioorg.2019.02.013","volume":"86","author":"F Turkan","year":"2019","unstructured":"Turkan F, Cetin A, Taslimi P et al (2019) Synthesis, biological evaluation and molecular docking of novel pyrazole derivatives as potent carbonic anhydrase and acetylcholinesterase inhibitors. Bioorg Chem 86:420\u2013427. https:\/\/doi.org\/10.1016\/j.bioorg.2019.02.013","journal-title":"Bioorg Chem"},{"key":"384_CR53","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1016\/S0162-0134(99)00152-X","volume":"76","author":"LCY Woo","year":"1999","unstructured":"Woo LCY, Yuen VG, Thompson KH et al (1999) Vanadyl\u2013biguanide complexes as potential synergistic insulin mimics. J Inorg Biochem 76:251\u2013257. https:\/\/doi.org\/10.1016\/S0162-0134(99)00152-X","journal-title":"J Inorg Biochem"},{"key":"384_CR54","doi-asserted-by":"publisher","first-page":"17017","DOI":"10.1039\/C4DT01392A","volume":"43","author":"Z Zhao","year":"2014","unstructured":"Zhao Z, Luo Z, Wu Q et al (2014) Mixed-ligand ruthenium polypyridyl complexes as apoptosis inducers in cancer cells, the cellular translocation and the important role of ROS-mediated signaling. Dalt Trans 43:17017\u201317028. https:\/\/doi.org\/10.1039\/C4DT01392A","journal-title":"Dalt Trans"},{"key":"384_CR55","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1002\/cmdc.201600509","volume":"12","author":"A Zubrien\u0117","year":"2017","unstructured":"Zubrien\u0117 A, Smirnov A, Dudutien\u0117 V et al (2017) Intrinsic thermodynamics and structures of 2,4- and 3,4-substituted fluorinated benzenesulfonamides binding to carbonic anhydrases. ChemMedChem 12:161\u2013176. https:\/\/doi.org\/10.1002\/cmdc.201600509","journal-title":"ChemMedChem"}],"container-title":["BioMetals"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10534-022-00384-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10534-022-00384-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10534-022-00384-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,7]],"date-time":"2022-06-07T22:04:39Z","timestamp":1654639479000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10534-022-00384-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3,30]]},"references-count":56,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2022,6]]}},"alternative-id":["384"],"URL":"https:\/\/doi.org\/10.1007\/s10534-022-00384-7","relation":{},"ISSN":["0966-0844","1572-8773"],"issn-type":[{"value":"0966-0844","type":"print"},{"value":"1572-8773","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,3,30]]},"assertion":[{"value":"5 July 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 March 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 March 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"A part of the present findings has been granted as a patent (Indian Patent No.338829, Granted on 11th September 2020, India). The authors declare no other conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}